This invention relates to the field of devices for use in operative surgery upon tissues of the body. More particularly, the invention relates to electrosurgical methods and systems for treatment of body tissues.
Electrosurgical devices use electrical energy, most commonly radio frequency (RF) energy, to cut tissue or to cauterize blood vessels. During use, a voltage gradient is created at the tip of the device, thereby inducing current flow and related heat generation in the tissue. With sufficiently high levels of electrical energy, the heat generated is sufficient to cut the tissue and, advantageously, to stop the bleeding from severed blood vessels.
Current electrosurgical devices can cause the temperature of tissue being treated to rise significantly higher than 100° C., resulting in tissue desiccation, tissue sticking to the electrodes, tissue perforation, char formation and smoke generation. Peak tissue temperatures as a result of RF treatment of target tissue can be as high as 320° C., and such high temperatures can be transmitted to adjacent tissue via thermal diffusion. Undesirable results of such transmission to adjacent tissue include unintended thermal damage to the tissue.
Using saline to couple RF electrical energy to tissue prevents such undesirable effects as sticking, desiccation, smoke production and char formation. One key factor is preventing tissue desiccation, which occurs if tissue temperature exceeds 100° C. and all of the intracellular water boils away, leaving the tissue extremely dry and much less electrically conductive. However, an uncontrolled flow rate of saline can provide too much cooling at the electrode/tissue interface. This cooling reduces the temperature of the target tissue being treated, and the rate at which tissue thermal coagulation occurs is determined by tissue temperature. This, in turn, can result in longer treatment time, to achieve the desired tissue temperature for cauterization or cutting of the tissue. Long treatment times are undesirable for surgeons since it is in the best interest of the patient, physician and hospital to perform surgical procedures as quickly as possible.
RF energy delivered to tissue is unpredictable and often not optimal when using general-purpose generators. Most general-purpose RF generators have modes for different waveforms (cut, coagulation, or a blend of these two) and device types (monopolar, bipolar), as well as power levels that can be set in watts. However, once these settings are chosen, the actual power delivered to tissue can vary dramatically over time as tissue impedance changes over the course of RF treatment. This is because the power delivered by most generators is a function of tissue impedance, with the power ramping down as impedance either decreases toward zero or increases significantly to several thousand ohms.
A further limitation of current electrosurgical devices arises from size constraints of the device in comparison to tissue that is encountered during a single surgical procedure. During the course of a single procedure, for example, a surgeon often encounters a wide variety of tissue sizes. Surgical devices often come in a variety of sizes because larger segments of tissue physically require commensurately larger electrode jaws or tips, but smaller segments of tissue often are not optimally treated by the much larger size RF device. It is undesirable to require numerous surgical devices during a single procedure, because this wastes valuable operating room time, can make it difficult to precisely relocate the treatment site, increases the risk of infection, and increases the cost by increasing the number of different surgical devices that are needed to complete the surgical procedure.
For example, a bipolar saline-enhanced tissue sealing forceps that has jaws long enough to effectively seal a 30 mm length of tissue may not be desirable for sealing a segment of tissue that is 10 mm in length. Excess saline from one of the electrode jaws (for a bipolar device) can flow to the other electrode in the space where there is no intervening tissue. This flow of electrically conductive saline can act as an electrical resistor in parallel with the electrical pathway through the target tissue. Electrical current flow through the saline can divert or shunt RF energy away from going through the target tissue, and slow down the rate at which the target tissue is heated and treated.
A surgeon may first be sealing and cutting lung tissue as part of a wedge resection using the full 30 mm jaw length 2-3 times to remove a tip of a lobe of lung for biopsy. If the intraoperative histopathology indicates that the suspected tissue has a malignant tumor, then the surgeon may convert the procedure to a lobectomy. As part of the lobectomy the surgeon will want to seal and cut large blood vessels that supply the lobe. Alternatively, the surgeon may want to toughen up or coagulate large vessels with RF and then apply a ligating clip to assure hemostasis before cutting. Even compressed, these blood vessels might only fill a small fraction of the 30 mm length of electrode jaw. For at least the reasons identified above, this is an undesirable situation with current electrosurgical devices.
The invention provides a system for treating tissue comprising a power measurement device, a flow rate controller coupled to the power measurement device, and an electrosurgical device configured and arranged to provide radio frequency power and conductive fluid to the tissue, wherein the flow rate controller is configured and arranged to modify a flow rate of the conductive fluid to the tissue, based on signals from the power measurement device.
Preferably, the flow rate controller modifies the flow rate of the conductive fluid to the tissue based on heat used to warm the conductive fluid and heat used to convert the conductive fluid to vapor. In a preferred embodiment, the flow rate controller modifies the flow rate of the conductive fluid to the tissue using the relationship:
In another embodiment, the invention provides a device for modifying flow rate of conductive fluid to tissue based on measurement of radio frequency power delivered to the tissue, the device comprising a flow rate controller configured and arranged to modify flow rate of the conductive fluid to the tissue, based on heat used to warm the conductive fluid and heat used to convert the conductive fluid to vapor. Preferably, the device modifies the flow rate of the conductive fluid to the tissue using the relationship:
In an alternative embodiment, the invention provides a device for treating tissue using radio frequency power and conductive fluid, the device comprising a sensing device, and a processor coupled to the sensing device, wherein the processor is configured and arranged to adjust flow rate of the conductive fluid to the tissue, by determining a level of radio frequency power applied to the tissue using the sensing device, and adjusting the flow rate of the conductive fluid to the tissue. Preferably, the processor is configured and arranged to adjust the flow rate of the conductive fluid to the tissue based on heat used to warm the conductive fluid and heat used to convert the conductive fluid to vapor. Preferably, the flow rate controller modifies the flow rate of the conductive fluid to the tissue using the relationship:
In another embodiment, the invention provides a method for treating tissue comprising applying radio frequency power and conductive fluid to the tissue using a surgical device, wherein the conductive fluid is provided to the tissue at a fluid flow rate, determining an amount of radio frequency power applied to the tissue, and modifying the fluid flow rate based on the power applied to the tissue. Preferably, the step of modifying the fluid flow rate based on the power applied to the tissue comprises modifying the flow rate of the conductive fluid to the tissue based on heat used to warm the conductive fluid and heat used to convert the conductive fluid to vapor. Preferably, the step of modifying the fluid flow rate based on the power applied to the tissue comprises determining the fluid flow rate using the relationship:
In an alternative embodiment, the invention provides a method for treating tissue comprising providing a surgical device comprising an electrode, wherein the surgical device is configured and arranged to receive radio frequency power and conductive fluid and deliver the radio frequency power and conductive fluid to the tissue, determining the radio frequency power applied to the tissue, and providing the conductive fluid to the tissue at a fluid flow rate, wherein the fluid flow rate is modified to control boiling of the conductive fluid at the tissue. Preferably, the step of providing the conductive fluid to the tissue at a fluid flow rate comprises providing the conductive fluid to the tissue based on heat used to warm the conductive fluid and heat used to convert the conductive fluid to vapor. In a preferred embodiment, the step of providing the conductive fluid to the tissue at a fluid flow rate comprises providing the conductive fluid to the tissue using the relationship:
In another embodiment, the invention provides a system for treating tissue comprising a power measurement device, a flow rate controller coupled to the power measurement device, a flow control device coupled to the flow rate controller, and an electrosurgical device coupled to the flow control device and the power measurement device, wherein the electrosurgical device is configured and arranged to provide radio frequency power and conductive fluid to the tissue, and wherein the flow rate controller is configured and arranged to modify a flow rate of the conductive fluid to the electrosurgical device, based on signals from the power measurement device. Preferably, the flow control device comprises a pump. In one embodiment, the pump comprises a peristaltic pump. In another embodiment, the pump comprises a syringe pump. Preferably, the electrosurgical device comprises a bipolar electrosurgical device.
According to this embodiment, the flow rate controller is preferably configured and arranged to modify the flow rate of the conductive fluid to the flow control device based on heat used to warm the conductive fluid and heat used to convert the conductive fluid to vapor. In a preferred embodiment, the flow rate controller is configured and arranged to modify the flow rate of the conductive fluid to the tissue using the relationship:
The invention can improve the speed of tissue coagulation provided by fluid-enhanced electrosurgery by assuring that the electrode-tissue interface is within a desired temperature range (for example, not significantly hotter than 100° C.) through the control of the fraction of conductive fluid that is boiled off at the electrode-tissue interface. This improvement can be achieved by measuring power provided to the device and regulating the flow of fluid to the device. Preferably, tissue sensors (for example, that would measure tissue temperature or tissue impedance) are not required according to the invention.
Some embodiments of the invention can provide one or more advantages, such as the ability to achieve the desired tissue effect (for example, coagulation, cutting, or the like) in a fast, effective manner. The invention can also provide the ability to treat tissue quickly without using a tissue sensor (for example, a temperature sensor) built into the device or a custom special-purpose generator. The invention can allow a surgeon to use a variety of electrosurgical devices with a wide variety of general-purpose generators. Further, the invention can provide the ability to use an electrosurgical device that is capable of quickly and effectively sealing a wide variety of tissue sizes and thicknesses.
a is a diagram that describes the equivalent electrical circuit for tissue in parallel with a single saline shunt.
b is a graph that describes the relationship of ratio of saline to tissue resistance (Rs/Rt) and percent power shunted into saline.
Overview
The invention provides a system, device and methods that preferably improve control of tissue temperature at a treatment site during a medical procedure. The invention is particularly useful during surgical procedures upon tissues of the body, where tissue is often cut and coagulated. The invention involves the use of electrosurgical procedures, which utilize RF power and conductive fluid to treat tissue. Preferably, a desired tissue temperature range is achieved through, adjusting parameters, such as conductive fluid flow rate, that affect the temperature at the tissue/electrode interface. Preferably, the device achieves a desired tissue temperature utilizing a desired percentage boiling of the conductive solution at the tissue/electrode interface. In a preferred embodiment, the invention provides a control device, the device comprising a flow rate controller that receives a signal indicating power applied to the system, and adjusts the flow rate of conductive fluid from a fluid source to an electrosurgical device. The invention also contemplates a control system comprising a flow rate controller, a measurement device that measures power applied to the system, and a pump that provides fluid at a desired flow rate.
The invention will be discussed generally with reference to
A generator 6 provides RF energy via a cable 7 to a power measurement device 8 that measures the RF electrical power. In this embodiment, the power measurement device 8 does not turn the power off or on or alter the power in any way. A power switch 15 connected to the generator 6 is provided by the generator manufacturer and is used to turn the generator 6 on and off. The power switch 15 can comprise any switch to turn the power on and off, and is commonly provided in the form of a footswitch or other easily operated switch. A cable 9 carries RF energy from the power measurement device 8 to the electrosurgical device 5. Power is preferably measured before it reaches the electrosurgical device.
A flow rate controller 11 includes a selection switch 12 that can be set to achieve desired levels of percentage fluid boiling (for example, 100%, 98%, 80% boiling). The flow rate controller 11 receives a signal 10 from the power measurement device 8 and calculates the correct fluid flow rate based on percentage boiling indicated by the selection switch 12. In a preferred embodiment, a fluid switch 13 is provided so that the fluid system can be primed (air eliminated) before turning the generator 6 on. The output signal 16 of the flow rate controller 11 is sent to the pump 3 motor to regulate the flow rate of conductive fluid, and thereby provide an appropriate fluid flow rate for the amount of power being delivered.
Throughout the present description, like reference numerals and letters indicate corresponding structure throughout the several views, and such corresponding structure need not be separately discussed.
In one embodiment, the invention comprises a flow rate controller that is configured and arranged to be connected to a source of RF power, and a source of conductive fluid. The device of the invention receives information about the level of RF power applied to an electrosurgical device, and adjusts the flow rate of the conductive fluid to the electrosurgical device, thereby controlling temperature at the tissue treatment site.
In another embodiment, elements of the system are physically included together in one electronic enclosure. One such embodiment is shown by enclosure within the outline box 14 of
The pump 3 can be any suitable pump used in surgical procedures to provide saline or other fluid at a desired flow rate. Preferably, the pump 3 comprises a peristaltic pump. Alternatively, pump 3 can be a “syringe pump,” with a built-in fluid supply; or a double-acting syringe pump with two syringes such that they can draw saline from a reservoir. Conductive fluid can also be provided from an intravenous (“I.V.”) bag full of saline that flows under the influence of gravity to the pump 3. Similar pumps can be used in connection with the invention, and the illustrated embodiments are exemplary only. The precise configuration of the pump 3 is not critical to the invention. In some embodiments, the pump can be substituted with any type of flow controller, to allow the user to control the flow rate of conductive fluid to the device. Alternatively, a valve configuration can be substituted for pump 3.
The components of the system will now be described in detail.
The Flow Rate Controller
The flow rate controller 11 controls the rate of flow from the fluid source 1, based upon the amount of RF power provided from the generator 6 to the electrosurgical device 5. The flow rate of conductive fluid, such as saline, interacts with the RF power and various modes of heat transfer away from the target tissue, as described herein.
P=ΔT/R+ρcρQlΔT+ρQbhv (1)
Where P=the total RF electrical power that is converted into heat.
Conduction. The first term [ΔT/R] in equation (1) is heat conducted to adjacent tissue, represented as 70 in
This thermal resistance can be estimated from published data gathered in experiments on human tissue (Phipps, J. H., “Thermometry studies with bipolar diathermy during hysterectomy,” Gynaecological Endoscopy, 3:5-7 (1994)). As described by Phipps, Kleppinger bipolar forceps were used with an RF power of 50 watts, and the peak tissue temperature reached 320° C. For example, using the energy balance of equation (1), and assuming all the RF heat put into tissue is conducted away, then R can be estimated:
R=ΔT/P=(320−37)/50=5.7≈6° C./watt
However, it is undesirable to allow the tissue temperature to reach 320° C., since tissue will become desiccated. At a temperature of 320° C., the fluid contained in the tissue is typically boiled away, resulting in the undesirable tissue effects described herein. Rather, it is preferred to keep the peak tissue temperature at no more than 100° C. to prevent desiccation of the tissue. Assuming that saline boils at 100° C., the first term in equation (1) (ΔT/R) is equal to (100−37)/6=10.5 watts. Thus, based on this example, the maximum amount of heat conducted to adjacent tissue without any significant risk of tissue desiccation is 10.5 watts.
Referring to
Convection. The second term [ρcρQlΔT] in equation (1) is heat used to warm up the flow of saline without boiling the saline, represented as 72 in
The onset of boiling can be predicted using equation (1) with the last term on the right set to zero (no boiling) (ρQbhv=0), and solving equation (1) for Ql leads to:
Ql=[P−ΔT/R]/ρcρΔT (2)
This equation defines the line shown in
Boiling. The third term [ρQbhv] in equation (1) relates to heat that goes into converting liquid saline to vapor saline and is represented as 74 in
A flow rate of only 1 cc/min will absorb a significant amount of heat if it is completely boiled, or about ρQbhv=(1) ( 1/60) (2,000)=33.3 watts. The heat needed to warm this flow rate from body temperature to 100° C. is much less, or ρcρQlΔT=(1) (4.1) ( 1/60) (100−37)=4.3 watts. In other words, the most significant factor contributing to heat transfer from a wet electrode device can be fractional boiling. The present invention recognizes this fact and exploits it.
Fractional boiling can be described by equation (3) below:
If the ratio of Qb/Ql is 0.50 this is the 50% boiling line 78 shown in
Control Strategy
Since the amount of heat conducted away to adjacent tissue is difficult to precisely predict, it is preferable, from a control point of view, to assume the worst case situation of zero heat conduction, and provide enough saline so that if necessary, all the RF power could be used to heat up and boil the saline, thus providing that the peak tissue temperature will not go over 100° C. a significant amount. This situation is shown in the schematic graph of
It is desirable to control the saline flow rate so that it is always on a “line of constant % boiling” for consistent tissue effect. If the device is monopolar and shunting through saline is not an issue, then it can be preferable to operate close to, but not over the line of the onset of boiling, 76a in
Ql=K×P (4)
In essence, when power P goes up, the flow rate Q will be proportionately increased. Conversely, when power P goes down, the flow rate Q will be proportionately decreased.
K is primarily dependent on the fraction of saline that boils, as shown in equation (5), which is equation (3) solved for K after eliminating P using equation (4), and neglecting the conduction term (ΔT/R):
Thus, the present invention provides a method of controlling boiling of conductive fluid at the tissue/electrode interface. In a preferred embodiment, this provides a method of treating tissue without use of tissue sensors, such as temperature or impedance sensors. Preferably, the invention can control boiling of conductive fluid at the tissue/electrode interface and thereby control tissue temperature without the use of feedback loops.
As discussed herein, RF energy delivery to tissue can be unpredictable and vary with time, even though the generator has been “set” to a fixed wattage.
The schematic graph of
Combining the effects shown in
According to the invention, the control device receives a signal indicating the drop in actual power delivered to the tissue and adjusts the flow rate of saline to maintain the tissue/electrode interface at a desired temperature. In a preferred embodiment, the drop in actual power delivered is sensed by the power measurement device 8 (shown in
The flow rate controller 11 of
As discussed herein, the saline can act as a shunt and divert energy away from target tissue. This is a phenomenon that can only occur with a bipolar device. In a monopolar device, saline can “pool” in the treatment area, and can, in some situations, divert energy by pooling. For the present discussion, shunting in connection with a bipolar device will be discussed.
In order to describe the underlying issue of saline shunting, an exemplary bipolar endoscopic electrosurgical device will be described in some detail. The bipolar electrosurgical device is described for purposes of illustrating the invention only, and it is understood that a wide variety of electrosurgical devices can be used in connection with the invention.
Preferably, the control device of the invention is used in connection with an electrosurgical device that is capable of controlling saline flow (for example, by controlling the location from which the saline is released from the electrosurgical device to the tissue). Any electrosurgical device that is capable of controlling saline flow is preferably used in connection with the invention described herein.
If the saline that flows from one electrode to the other is not boiling in any significant manner, a large fraction of the RF energy can be diverted away from target tissue. This “stealing” of RF energy tends to dramatically slow down the process of coagulating tissue and producing the desired hemostasis or aerostasis of the tissue. This situation is illustrated in
The saline shunting scenario can also be explained by using an electrical circuit as shown in
In the embodiment illustrated in
One benefit of the flow rate control strategy described herein, where a high % boiling is maintained, is that the flow of saline from one electrode to the other is either eliminated altogether because all the flow boils off at the electrode/tissue interface, or a large fraction of the flow boils as it flows toward the other electrode. This second case is illustrated in
One aspect of the control strategy of the invention is that the flow of saline is preferably primarily directed spatially against or very near the target tissue that is to receive the RF power. If the flow rate is not near where the RF power is turned into heat, the saline is not capable of protecting the tissue from desiccation by dissipating excess heat in the boiling process. Therefore, in a preferred embodiment, the flow of conductive fluid is directly primarily at the tissue treatment site.
Use
Typically a surgeon will grasp a small amount of tissue with the very tip of the device as shown in
Generally, the holes 26 or 26a of the electrode 25 supply conductive fluid to the treatment site. In an alternative embodiment, these holes are provided in the form of porous material such as metal. In this embodiment, the electrodes do not include discrete holes; rather, the electrode surface itself is porous to allow infusion of the conductive solution to the treatment site. Porous sintered metal is available in many materials (such as, for example, 316L stainless steel, titanium, Ni-Chrome, and the like) and shapes (such as cylinders, discs, plugs, and the like) from companies such as Porvair, located in Henderson, N.C.
Porous metal components can be formed by a sintered metal powder process or by injection molding a two-part combination of metal and a material that can be burned off to form pores that connect (open cell) to each other. Such methods are known in the art. In this embodiment, conductive fluid will flow out of the electrode everywhere the pores are open. Preferably, the exterior (that is, the portions of the components that do not comprise the portion of the device involved in tissue treatment) of such porous metal electrode components can be covered with a material that fills the pores and prevents both the flow of saline and the passing of electrical energy. Alternatively, the device can include gutters to prevent the flow of saline in areas where it is desired to prevent saline flow.
In yet another embodiment, a porous polymer is used in place of the porous metal. Although the polymer is non-conductive, the conductive solution provided will conduct the RF energy across the porous polymer wall and to the tissue to be treated. Suitable materials include high temperature open cell silicone foam and porous polycarbonates, among others. Porous ceramics also fall into this category, since they could distribute conductive fluid flow, withstand high temperatures and be machinable or moldable for manufacturing purposes. Preferably, the material used transmits both fluid flow and electrical energy; thus, materials with properties between high-electrical conductivity metals and low electrical conductivity polymers are also contemplated, such as porous carbon-filled polymers. In these embodiments, conductive fluid flow is distributed along the length of the electrodes, where porous material is used to fabricate the electrodes. All or a portion of the electrodes can be porous according to the invention.
While the invention has been described in relation to a bipolar electrosurgical device, it will be readily apparent that other electrosurgical devices can be easily adapted to be used in connection with the invention. For example, the electrosurgical device 5 in
Other suitable electrosurgical devices that can be used in connection with the invention described herein include, but are not limited to, devices described in U.S. patent application Ser. No. 09/668,403 (filed 22 Sep. 2000), U.S. Pat. No. 5,897,553 (issued 27 Apr. 1999), U.S. Pat. No. 6,063,081 (issued 16 May 2000), and U.S. Pat. No. 6,096,037 (issued 1 Aug. 2000).
Moreover, it will be readily apparent that other means can be used to provide heat to the tissue, in addition to the radio frequency power described herein.
One or more of the features of the previously described system can be built into a custom RF generator. This embodiment can provide one or more advantages. For example, this type of system can save space and reduce overall complexity for the user. This system can also enable the manufacturer to increase the power delivered into low impedance loads, thereby further reducing the time to achieve the desired tissue effects. This changes the curve of
To effectively treat thick tissues, it can be advantageous to have the ability to pulse the RF power on and off. Under some circumstances, the temperature deep in tissue can rise quickly past the 100° C. desiccation point even though the electrode/tissue interface is boiling at 100° C. This manifests itself as “popping,” as steam generated deep in the tissue boils too fast and erupts toward the surface. In one embodiment of the invention, a switch is provided on the control device or custom generator to allow the user to select a “pulse” mode of the RF power. Preferably, the RF power system in this embodiment is further controlled by software.
In some embodiments, it can be desirable to control the temperature of the conductive fluid before it is released from the electrosurgical device. In one embodiment, a heat exchanger is provided for the outgoing saline flow to either heat or chill the saline. Pre-heating the saline to a predetermined level below boiling reduces the transient warm-up time of the device as RF is initially turned on, thereby reducing the time to cause coagulation of tissue. Alternatively, pre-chilling the saline is useful when the surgeon desires to protect certain tissues at the electrode/tissue interface and treat only deeper tissue. One exemplary application of this embodiment is the treatment of varicose veins, where it is desirable to avoid thermal damage to the surface of the skin. At the same time, treatment is provided to shrink underlying blood vessels using thermal coagulation. The temperature of the conductive fluid prior to release from the surgical device can therefore be controlled, to provide the desired treatment effect.
In another embodiment, the flow rate controller is modified to provide for a saline flow rate that results in greater than 100% boiling at the tissue treatment site. For example, the selection switch 12 of the flow rate controller 11 (shown in
Some embodiments of the invention can provide one or more advantages over current electrosurgical techniques and devices. For example, the invention preferably achieves the desired tissue effect (for example, coagulation, cutting, and the like) in a fast manner. In a preferred embodiment, by actively controlling the flow rate of saline, both in quantity (Q vs. P) and location (for example, using gutters to direct fluid distally to tissue, using holes to direct flow of fluid, or other similar methods) the electrosurgical device can create a hot non-desiccating electrode/tissue interface and thus a fast thermally induced tissue coagulation effect.
The invention can, in some embodiments, deliver fast treatment of tissue without using a temperature sensor built into the device or a custom special-purpose generator. In a preferred embodiment, there is no built-in temperature sensor or other type of tissue sensor, nor is there any custom generator. Preferably, the invention provides a means for controlling the flow rate to the device such that the device and flow rate controller can be used with a wide variety of general-purpose generators. Any general-purpose generator is useable in connection with the fluid delivery system and flow rate controller to provide the desired power; the flow rate controller will accept the power and constantly adjust the saline flow rate according to the control strategy. Preferably, the generator is not actively controlled by the invention, so that standard generators are useable according to the invention. Preferably, there is no active feedback from the device and the control of the saline flow rate is “open loop.” Thus, in this embodiment, the control of saline flow rate is not dependent on feedback, but rather the measurement of the RF power going out to the device.
In another aspect, the invention preferably provides an electrosurgical device design that is capable of quickly and effectively sealing a wide variety of tissue segment sizes. The electrosurgical device provides a number of characteristics that improve the ability to treat a wide variety of tissue size and thickness. For example, a preferred embodiment provides the ability to control the saline flow towards a high percentage boiling, for example, 80-100%. This reduces shunting of the RF by boiling off saline before it could flow to the other electrode, or by boiling the saline as it is in the process of flowing to the other electrode. In another aspect, one preferred embodiment includes gutters in connection with the electrodes. In this embodiment, saline flow is directed toward the tissue treatment site, thereby providing all or substantially all of the conductive fluid to the treatment site. Thus, the tissue being treated is sufficiently “protected” from desiccation by utilizing the controlled conductive fluid boiling described herein. Preferably, the tissue-activated jaws offer another way to provide the conductive fluid in proximity to where the RF power is turned into heat.
While a preferred embodiment of the present invention has been described, it should be understood that various changes, adaptations and modifications can be made therein without departing from the spirit of the invention and the scope of the appended claims. The scope of the invention should, therefore, be determined not with reference to the above description, but instead should be determined with reference to the appended claims along with their full scope of equivalents.
All publications and patent documents cited in this application are incorporated by reference in their entirety for all purposes to the extent they are not inconsistent with the teachings herein.
This application is a continuation of U.S. application Ser. No. 09/797,049, filed Mar. 1, 2001, now U.S. Pat. No. 6,702,810, which claimed priority under 35 U.S.C. 119(e) to U.S. provisional application Ser. No. 60/187,114, filed Mar. 6, 2000.
Number | Name | Date | Kind |
---|---|---|---|
623022 | Johnson | Apr 1899 | A |
1735271 | Groff | Nov 1929 | A |
1814791 | Ende | Jul 1931 | A |
2002594 | Wappler et al. | May 1935 | A |
2031682 | Wappler et al. | Feb 1936 | A |
2102270 | Hyams | Dec 1937 | A |
2275167 | Bierman | Mar 1942 | A |
2888928 | Seiger | Jun 1959 | A |
3163166 | Brent et al. | Dec 1964 | A |
3682130 | Jeffers | Aug 1972 | A |
3750650 | Ruttgers | Aug 1973 | A |
3901241 | Allen, Jr. | Aug 1975 | A |
4037590 | Dohring et al. | Jul 1977 | A |
4060088 | Morrison, Jr. et al. | Nov 1977 | A |
4116198 | Roos | Sep 1978 | A |
4244371 | Farin | Jan 1981 | A |
4276874 | Wolvek et al. | Jul 1981 | A |
4301802 | Poler | Nov 1981 | A |
4307720 | Weber, Jr. | Dec 1981 | A |
4321931 | Hon | Mar 1982 | A |
4326529 | Doss et al. | Apr 1982 | A |
4342218 | Fox | Aug 1982 | A |
4355642 | Alferness | Oct 1982 | A |
4381007 | Doss | Apr 1983 | A |
4532924 | Auth et al. | Aug 1985 | A |
4567890 | Ohta et al. | Feb 1986 | A |
4602628 | Allen, Jr. | Jul 1986 | A |
4671274 | Sorochenko | Jun 1987 | A |
4674499 | Pao | Jun 1987 | A |
4919129 | Weber, Jr. | Apr 1990 | A |
4920982 | Goldstein | May 1990 | A |
4931047 | Broadwin et al. | Jun 1990 | A |
4932952 | Wojciechowicz, Jr. | Jun 1990 | A |
4943290 | Rexroth et al. | Jul 1990 | A |
4950232 | Ruzicka et al. | Aug 1990 | A |
4976711 | Parins et al. | Dec 1990 | A |
4985030 | Melzer et al. | Jan 1991 | A |
4998933 | Eggers et al. | Mar 1991 | A |
5009656 | Reimels | Apr 1991 | A |
5013312 | Parins et al. | May 1991 | A |
5035696 | Rydell | Jul 1991 | A |
5071419 | Rydell et al. | Dec 1991 | A |
5080660 | Buelna | Jan 1992 | A |
5122138 | Manwaring | Jun 1992 | A |
5125928 | Parins et al. | Jun 1992 | A |
5147357 | Rose et al. | Sep 1992 | A |
5151102 | Kamiyama et al. | Sep 1992 | A |
5156613 | Sawyer | Oct 1992 | A |
5167659 | Ohtomo et al. | Dec 1992 | A |
5171311 | Rydell et al. | Dec 1992 | A |
5190541 | Abele et al. | Mar 1993 | A |
5195959 | Smith | Mar 1993 | A |
5197963 | Parins | Mar 1993 | A |
5197964 | Parins | Mar 1993 | A |
5217460 | Knoepfler | Jun 1993 | A |
5234428 | Kaufman | Aug 1993 | A |
5242441 | Avitall | Sep 1993 | A |
5242442 | Hirschfeld | Sep 1993 | A |
5254117 | Rigby | Oct 1993 | A |
5269780 | Roos | Dec 1993 | A |
5269781 | Hewell, III | Dec 1993 | A |
5277696 | Hagen | Jan 1994 | A |
5281215 | Milder | Jan 1994 | A |
5281216 | Klicek | Jan 1994 | A |
5282799 | Rydell | Feb 1994 | A |
5290286 | Parins | Mar 1994 | A |
5300087 | Knoepfler | Apr 1994 | A |
5313943 | Houser et al. | May 1994 | A |
5318589 | Lichtman | Jun 1994 | A |
5322503 | Desai | Jun 1994 | A |
5330521 | Cohen | Jul 1994 | A |
5334193 | Nardella | Aug 1994 | A |
5336220 | Ryan | Aug 1994 | A |
5342357 | Nardella | Aug 1994 | A |
5342359 | Rydell | Aug 1994 | A |
5348554 | Imran et al. | Sep 1994 | A |
5364394 | Mehl | Nov 1994 | A |
5383874 | Jackson et al. | Jan 1995 | A |
5383876 | Nardella | Jan 1995 | A |
5395312 | Desai | Mar 1995 | A |
5395363 | Billings et al. | Mar 1995 | A |
5401272 | Perkins | Mar 1995 | A |
5403311 | Abele et al. | Apr 1995 | A |
5403312 | Yates et al. | Apr 1995 | A |
5405344 | Williamson et al. | Apr 1995 | A |
5405376 | Mulier et al. | Apr 1995 | A |
5417672 | Nita et al. | May 1995 | A |
5417709 | Slater | May 1995 | A |
5431168 | Webster et al. | Jul 1995 | A |
5431649 | Mulier et al. | Jul 1995 | A |
5433708 | Nichols et al. | Jul 1995 | A |
5437662 | Nardella | Aug 1995 | A |
5437664 | Cohen et al. | Aug 1995 | A |
5441498 | Perkins | Aug 1995 | A |
5441503 | Considine et al. | Aug 1995 | A |
5445638 | Rydell et al. | Aug 1995 | A |
5456682 | Edwards et al. | Oct 1995 | A |
5456684 | Schmidt et al. | Oct 1995 | A |
5458596 | Lax et al. | Oct 1995 | A |
5458597 | Edwards et al. | Oct 1995 | A |
5458598 | Feinberg et al. | Oct 1995 | A |
5460629 | Shlain et al. | Oct 1995 | A |
5462521 | Brucker et al. | Oct 1995 | A |
5472441 | Edwards et al. | Dec 1995 | A |
5472443 | Cordis et al. | Dec 1995 | A |
5487385 | Avitall | Jan 1996 | A |
5490819 | Nicholas et al. | Feb 1996 | A |
5500012 | Brucker et al. | Mar 1996 | A |
5514130 | Baker | May 1996 | A |
5522815 | Durgin, Jr. et al. | Jun 1996 | A |
5536267 | Edwards et al. | Jul 1996 | A |
5540562 | Giter | Jul 1996 | A |
5542928 | Evans et al. | Aug 1996 | A |
5542945 | Fritzsch | Aug 1996 | A |
5556397 | Long | Sep 1996 | A |
5558671 | Yates | Sep 1996 | A |
5562503 | Ellman et al. | Oct 1996 | A |
5562702 | Huitema et al. | Oct 1996 | A |
5562703 | Desai | Oct 1996 | A |
5564440 | Swartz et al. | Oct 1996 | A |
5569242 | Lax et al. | Oct 1996 | A |
5569243 | Kortenbach et al. | Oct 1996 | A |
5573424 | Poppe | Nov 1996 | A |
5573533 | Strul | Nov 1996 | A |
5575810 | Swanson et al. | Nov 1996 | A |
5584872 | LaFontaine et al. | Dec 1996 | A |
5599346 | Edwards et al. | Feb 1997 | A |
5599350 | Schulze et al. | Feb 1997 | A |
5605539 | Buelna et al. | Feb 1997 | A |
5609151 | Mulier et al. | Mar 1997 | A |
5633578 | Eggers et al. | May 1997 | A |
5637110 | Pennybacker et al. | Jun 1997 | A |
5640955 | Ockuly et al. | Jun 1997 | A |
5643197 | Brucker et al. | Jul 1997 | A |
5647869 | Goble et al. | Jul 1997 | A |
5647871 | Levine et al. | Jul 1997 | A |
5653692 | Masterson et al. | Aug 1997 | A |
5660836 | Knowlton | Aug 1997 | A |
5676662 | Fleischhacker et al. | Oct 1997 | A |
5676693 | LaFontaine | Oct 1997 | A |
5681282 | Eggers et al. | Oct 1997 | A |
5681294 | Osborne et al. | Oct 1997 | A |
5683366 | Eggers et al. | Nov 1997 | A |
5683384 | Gough et al. | Nov 1997 | A |
5687723 | Avitall | Nov 1997 | A |
5688270 | Yates et al. | Nov 1997 | A |
5693045 | Eggers | Dec 1997 | A |
5697281 | Eggers et al. | Dec 1997 | A |
5697536 | Eggers et al. | Dec 1997 | A |
5697882 | Eggers et al. | Dec 1997 | A |
5697909 | Eggers et al. | Dec 1997 | A |
5697927 | Imran et al. | Dec 1997 | A |
5702386 | Stern et al. | Dec 1997 | A |
5709680 | Yates et al. | Jan 1998 | A |
5713896 | Nardella | Feb 1998 | A |
5718241 | Ben-Haim et al. | Feb 1998 | A |
5718701 | Shai et al. | Feb 1998 | A |
5718703 | Chin | Feb 1998 | A |
5722400 | Ockuly et al. | Mar 1998 | A |
5725524 | Mulier et al. | Mar 1998 | A |
5730127 | Avitall | Mar 1998 | A |
5735846 | Panescu et al. | Apr 1998 | A |
5743903 | Stern et al. | Apr 1998 | A |
5746739 | Sutter | May 1998 | A |
5749869 | Lindenmeier et al. | May 1998 | A |
5755717 | Yates et al. | May 1998 | A |
5755753 | Knowlton | May 1998 | A |
5766153 | Eggers et al. | Jun 1998 | A |
5766167 | Eggers et al. | Jun 1998 | A |
5785705 | Baker | Jul 1998 | A |
5785706 | Bednarek | Jul 1998 | A |
5792140 | Tu et al. | Aug 1998 | A |
5797905 | Fleischman et al. | Aug 1998 | A |
5797960 | Stevens et al. | Aug 1998 | A |
5800413 | Swartz et al. | Sep 1998 | A |
5800482 | Pomeranz et al. | Sep 1998 | A |
5807393 | Williamson et al. | Sep 1998 | A |
5807395 | Mulier et al. | Sep 1998 | A |
5810764 | Eggers et al. | Sep 1998 | A |
5810805 | Sutcu et al. | Sep 1998 | A |
5810811 | Yates et al. | Sep 1998 | A |
5817093 | Williamson et al. | Oct 1998 | A |
5823956 | Roth et al. | Oct 1998 | A |
5827271 | Buysse et al. | Oct 1998 | A |
5827281 | Levin | Oct 1998 | A |
5833703 | Manushakian | Nov 1998 | A |
5843019 | Eggers et al. | Dec 1998 | A |
5843021 | Edwards et al. | Dec 1998 | A |
5843078 | Sharkey | Dec 1998 | A |
5843152 | Tu et al. | Dec 1998 | A |
5855614 | Stevens et al. | Jan 1999 | A |
5860951 | Eggers et al. | Jan 1999 | A |
5860974 | Abele | Jan 1999 | A |
5861002 | Desai | Jan 1999 | A |
5861021 | Thome et al. | Jan 1999 | A |
5868739 | Lindenmeier et al. | Feb 1999 | A |
5871469 | Eggers et al. | Feb 1999 | A |
5871524 | Knowlton | Feb 1999 | A |
5873855 | Eggers et al. | Feb 1999 | A |
5876398 | Mulier et al. | Mar 1999 | A |
5879348 | Owens et al. | Mar 1999 | A |
5888198 | Eggers et al. | Mar 1999 | A |
5891095 | Eggers et al. | Apr 1999 | A |
5891141 | Rydell | Apr 1999 | A |
5891142 | Eggers et al. | Apr 1999 | A |
5893848 | Negus et al. | Apr 1999 | A |
5895355 | Schaer | Apr 1999 | A |
5895417 | Pomeranz et al. | Apr 1999 | A |
5897553 | Mulier et al. | Apr 1999 | A |
5902272 | Eggers et al. | May 1999 | A |
5902328 | LaFontaine et al. | May 1999 | A |
5904711 | Flom et al. | May 1999 | A |
5906613 | Mulier et al. | May 1999 | A |
5913854 | Maguire et al. | Jun 1999 | A |
5913856 | Chia et al. | Jun 1999 | A |
5919191 | Lennox et al. | Jul 1999 | A |
5919219 | Knowlton | Jul 1999 | A |
5921982 | Lesh et al. | Jul 1999 | A |
5921983 | Shannon, Jr. | Jul 1999 | A |
5925045 | Reimels et al. | Jul 1999 | A |
5935123 | Edwards et al. | Aug 1999 | A |
5944715 | Goble | Aug 1999 | A |
5948011 | Knowlton | Sep 1999 | A |
5951549 | Richardson et al. | Sep 1999 | A |
5954716 | Sharkey et al. | Sep 1999 | A |
5957919 | Laufer | Sep 1999 | A |
5964755 | Edwards | Oct 1999 | A |
5971983 | Lesh | Oct 1999 | A |
5976128 | Schilling et al. | Nov 1999 | A |
5980504 | Sharkey et al. | Nov 1999 | A |
5980516 | Mulier et al. | Nov 1999 | A |
5989248 | Tu et al. | Nov 1999 | A |
5992418 | de la Rama et al. | Nov 1999 | A |
5993412 | Deily et al. | Nov 1999 | A |
6003517 | Sheffield et al. | Dec 1999 | A |
6004316 | Laufer | Dec 1999 | A |
6004319 | Goble et al. | Dec 1999 | A |
6007570 | Sharkey et al. | Dec 1999 | A |
6010500 | Sherman et al. | Jan 2000 | A |
6015391 | Rishton et al. | Jan 2000 | A |
6015407 | Rieb et al. | Jan 2000 | A |
6016809 | Mulier et al. | Jan 2000 | A |
6017338 | Brucker et al. | Jan 2000 | A |
6018676 | Davis et al. | Jan 2000 | A |
6019757 | Scheldrup | Feb 2000 | A |
6024733 | Eggers et al. | Feb 2000 | A |
6027501 | Goble et al. | Feb 2000 | A |
6030379 | Panescu et al. | Feb 2000 | A |
6030381 | Jones | Feb 2000 | A |
6032077 | Pomeranz | Feb 2000 | A |
6032674 | Eggers et al. | Mar 2000 | A |
6033398 | Farley et al. | Mar 2000 | A |
6035238 | Ingle et al. | Mar 2000 | A |
6036687 | Laufer et al. | Mar 2000 | A |
6045532 | Eggers et al. | Apr 2000 | A |
6047700 | Eggers et al. | Apr 2000 | A |
6048333 | Lennox et al. | Apr 2000 | A |
6053172 | Hovda et al. | Apr 2000 | A |
6053912 | Panescu et al. | Apr 2000 | A |
6056744 | Edwards | May 2000 | A |
6056745 | Panescu et al. | May 2000 | A |
6056746 | Goble | May 2000 | A |
6056747 | Saadat et al. | May 2000 | A |
6059781 | Yamanashi et al. | May 2000 | A |
6063079 | Hovda et al. | May 2000 | A |
6063081 | Mulier et al. | May 2000 | A |
6066134 | Eggers et al. | May 2000 | A |
6066139 | Ryan et al. | May 2000 | A |
6068627 | Orszulak et al. | May 2000 | A |
6068653 | LaFontaine | May 2000 | A |
6071280 | Edwards et al. | Jun 2000 | A |
6073051 | Sharkey et al. | Jun 2000 | A |
6074389 | Levine et al. | Jun 2000 | A |
6080151 | Swartz et al. | Jun 2000 | A |
6081749 | Ingle et al. | Jun 2000 | A |
6083237 | Huitema et al. | Jul 2000 | A |
6086585 | Hovda et al. | Jul 2000 | A |
6086586 | Hooven | Jul 2000 | A |
6091995 | Ingle et al. | Jul 2000 | A |
6093186 | Goble | Jul 2000 | A |
6095149 | Sharkey et al. | Aug 2000 | A |
6096037 | Mulier et al. | Aug 2000 | A |
6099514 | Sharkey et al. | Aug 2000 | A |
6102046 | Weinstein et al. | Aug 2000 | A |
6105581 | Eggers et al. | Aug 2000 | A |
6109268 | Thapliyal et al. | Aug 2000 | A |
6113596 | Hooven et al. | Sep 2000 | A |
6113597 | Eggers et al. | Sep 2000 | A |
6117109 | Eggers et al. | Sep 2000 | A |
6122549 | Sharkey et al. | Sep 2000 | A |
H1904 | Yates et al. | Oct 2000 | H |
6126682 | Sharkey et al. | Oct 2000 | A |
6135999 | Fanton et al. | Oct 2000 | A |
6141576 | Littmann et al. | Oct 2000 | A |
6142992 | Cheng et al. | Nov 2000 | A |
6149620 | Baker et al. | Nov 2000 | A |
6159194 | Eggers et al. | Dec 2000 | A |
6159208 | Hovda et al. | Dec 2000 | A |
6165169 | Panescu et al. | Dec 2000 | A |
6165175 | Wampler et al. | Dec 2000 | A |
6168594 | LaFontaine et al. | Jan 2001 | B1 |
6171275 | Webster, Jr. | Jan 2001 | B1 |
6174308 | Goble et al. | Jan 2001 | B1 |
6174309 | Wrublewski et al. | Jan 2001 | B1 |
6176857 | Ashley | Jan 2001 | B1 |
6179824 | Eggers et al. | Jan 2001 | B1 |
6179836 | Eggers et al. | Jan 2001 | B1 |
6183469 | Thapliyal et al. | Feb 2001 | B1 |
6190381 | Olsen et al. | Feb 2001 | B1 |
6190384 | Ouchi | Feb 2001 | B1 |
6193715 | Wrublewski et al. | Feb 2001 | B1 |
6193716 | Shannon, Jr. | Feb 2001 | B1 |
6203542 | Ellsberry et al. | Mar 2001 | B1 |
6210402 | Olsen et al. | Apr 2001 | B1 |
6210406 | Webster | Apr 2001 | B1 |
6210410 | Farin et al. | Apr 2001 | B1 |
6210411 | Hofmann et al. | Apr 2001 | B1 |
6212426 | Swanson | Apr 2001 | B1 |
6216704 | Ingle et al. | Apr 2001 | B1 |
6217576 | Tu et al. | Apr 2001 | B1 |
6221039 | Durgin et al. | Apr 2001 | B1 |
6221069 | Daikuzono | Apr 2001 | B1 |
6224592 | Eggers et al. | May 2001 | B1 |
6224593 | Ryan et al. | May 2001 | B1 |
6226554 | Tu et al. | May 2001 | B1 |
6228078 | Eggers et al. | May 2001 | B1 |
6228082 | Baker et al. | May 2001 | B1 |
6231591 | Desai | May 2001 | B1 |
6235020 | Cheng et al. | May 2001 | B1 |
6236891 | Ingle et al. | May 2001 | B1 |
6238387 | Miller, III | May 2001 | B1 |
6238391 | Olsen et al. | May 2001 | B1 |
6238393 | Mulier et al. | May 2001 | B1 |
6241753 | Knowlton | Jun 2001 | B1 |
6241754 | Swanson et al. | Jun 2001 | B1 |
6251110 | Wampler | Jun 2001 | B1 |
6254600 | Willink et al. | Jul 2001 | B1 |
6258086 | Ashley et al. | Jul 2001 | B1 |
6258087 | Edwards et al. | Jul 2001 | B1 |
6261311 | Sharkey et al. | Jul 2001 | B1 |
6264650 | Hovda et al. | Jul 2001 | B1 |
6264651 | Underwood et al. | Jul 2001 | B1 |
6264652 | Eggers et al. | Jul 2001 | B1 |
6264654 | Swartz et al. | Jul 2001 | B1 |
6266551 | Osadchy et al. | Jul 2001 | B1 |
6277112 | Underwood et al. | Aug 2001 | B1 |
6280440 | Gocho | Aug 2001 | B1 |
6283961 | Underwood et al. | Sep 2001 | B1 |
6283988 | Laufer et al. | Sep 2001 | B1 |
6283989 | Laufer et al. | Sep 2001 | B1 |
6290715 | Sharkey et al. | Sep 2001 | B1 |
6293942 | Goble et al. | Sep 2001 | B1 |
6293945 | Parins et al. | Sep 2001 | B1 |
6296636 | Cheng et al. | Oct 2001 | B1 |
6296638 | Davison et al. | Oct 2001 | B1 |
6296640 | Wampler et al. | Oct 2001 | B1 |
6299633 | Laufer | Oct 2001 | B1 |
6302903 | Mulier et al. | Oct 2001 | B1 |
6306134 | Goble et al. | Oct 2001 | B1 |
6309387 | Eggers et al. | Oct 2001 | B1 |
6311090 | Knowlton | Oct 2001 | B1 |
6312408 | Eggers et al. | Nov 2001 | B1 |
6312430 | Wilson et al. | Nov 2001 | B1 |
6315777 | Comben | Nov 2001 | B1 |
6322549 | Eggers et al. | Nov 2001 | B1 |
6322559 | Daulton et al. | Nov 2001 | B1 |
6327505 | Medhkour et al. | Dec 2001 | B1 |
6328735 | Curley et al. | Dec 2001 | B1 |
6328736 | Mulier et al. | Dec 2001 | B1 |
6336926 | Goble | Jan 2002 | B1 |
6350262 | Ashley | Feb 2002 | B1 |
6350276 | Knowlton | Feb 2002 | B1 |
6352533 | Ellman et al. | Mar 2002 | B1 |
6355032 | Hovda et al. | Mar 2002 | B1 |
6358245 | Edwards et al. | Mar 2002 | B1 |
6358248 | Mulier et al. | Mar 2002 | B1 |
6363937 | Hovda et al. | Apr 2002 | B1 |
6371956 | Wilson et al. | Apr 2002 | B1 |
6379350 | Sharkey et al. | Apr 2002 | B1 |
6379351 | Thapliyal et al. | Apr 2002 | B1 |
6391025 | Weinstein et al. | May 2002 | B1 |
6391028 | Fanton et al. | May 2002 | B1 |
6402742 | Blewett et al. | Jun 2002 | B1 |
6409722 | Hoey et al. | Jun 2002 | B1 |
6409723 | Edwards | Jun 2002 | B1 |
H2037 | Yates et al. | Jul 2002 | H |
6416507 | Eggers et al. | Jul 2002 | B1 |
6416508 | Eggers et al. | Jul 2002 | B1 |
6416509 | Goble et al. | Jul 2002 | B1 |
6425877 | Edwards | Jul 2002 | B1 |
6432103 | Ellsberry et al. | Aug 2002 | B1 |
6440130 | Mulier et al. | Aug 2002 | B1 |
6443952 | Mulier et al. | Sep 2002 | B1 |
6451017 | Moutafis et al. | Sep 2002 | B1 |
6458123 | Brucker et al. | Oct 2002 | B1 |
6458130 | Frazier et al. | Oct 2002 | B1 |
6461350 | Underwood et al. | Oct 2002 | B1 |
6461354 | Olsen et al. | Oct 2002 | B1 |
6461357 | Sharkey et al. | Oct 2002 | B1 |
6464695 | Hovda et al. | Oct 2002 | B2 |
6468270 | Hovda et al. | Oct 2002 | B1 |
6468274 | Alleyne et al. | Oct 2002 | B1 |
6468275 | Wampler et al. | Oct 2002 | B1 |
6471698 | Edwards et al. | Oct 2002 | B1 |
6475216 | Mulier et al. | Nov 2002 | B2 |
6478793 | Cosman et al. | Nov 2002 | B1 |
6482202 | Goble et al. | Nov 2002 | B1 |
6485490 | Wampler et al. | Nov 2002 | B2 |
6488680 | Francischelli et al. | Dec 2002 | B1 |
6493589 | Medhkour et al. | Dec 2002 | B1 |
6494902 | Hoey et al. | Dec 2002 | B2 |
6497704 | Ein-Gai | Dec 2002 | B2 |
6497705 | Comben | Dec 2002 | B2 |
6506189 | Rittman, III et al. | Jan 2003 | B1 |
6508815 | Strul et al. | Jan 2003 | B1 |
6517536 | Hooven et al. | Feb 2003 | B2 |
6526320 | Mitchell | Feb 2003 | B2 |
6537248 | Mulier et al. | Mar 2003 | B2 |
6537272 | Christopherson et al. | Mar 2003 | B2 |
6539265 | Medhkour et al. | Mar 2003 | B2 |
6558379 | Batchelor et al. | May 2003 | B1 |
6558385 | McClurken et al. | May 2003 | B1 |
6575969 | Rittman et al. | Jun 2003 | B1 |
6577902 | Laufer et al. | Jun 2003 | B1 |
6579288 | Swanson et al. | Jun 2003 | B1 |
6585732 | Mulier et al. | Jul 2003 | B2 |
6602248 | Sharps et al. | Aug 2003 | B1 |
6603988 | Dowlatshahi | Aug 2003 | B2 |
6610060 | Mulier et al. | Aug 2003 | B2 |
6613048 | Mulier et al. | Sep 2003 | B2 |
6623515 | Mulier et al. | Sep 2003 | B2 |
6626899 | Houser et al. | Sep 2003 | B2 |
6635034 | Cosmescu | Oct 2003 | B1 |
6645202 | Pless et al. | Nov 2003 | B1 |
6666862 | Jain et al. | Dec 2003 | B2 |
6669692 | Nelson et al. | Dec 2003 | B1 |
6676660 | Wampler | Jan 2004 | B2 |
6679882 | Kornerup | Jan 2004 | B1 |
6682501 | Nelson et al. | Jan 2004 | B1 |
6682527 | Strul | Jan 2004 | B2 |
6682528 | Frazier et al. | Jan 2004 | B2 |
6685700 | Behl et al. | Feb 2004 | B2 |
6685701 | Orszulak et al. | Feb 2004 | B2 |
6685704 | Greep | Feb 2004 | B2 |
6689129 | Baker | Feb 2004 | B2 |
6689131 | McClurken | Feb 2004 | B2 |
6692489 | Heim et al. | Feb 2004 | B1 |
6694984 | Habib | Feb 2004 | B2 |
6695837 | Howell | Feb 2004 | B2 |
6695840 | Schulze | Feb 2004 | B2 |
6699240 | Francischelli | Mar 2004 | B2 |
6699242 | Heggeness | Mar 2004 | B2 |
6699244 | Carranza et al. | Mar 2004 | B2 |
6699268 | Kordis et al. | Mar 2004 | B2 |
6702810 | McClurken et al. | Mar 2004 | B2 |
6702812 | Cosmescu | Mar 2004 | B2 |
6706039 | Mulier et al. | Mar 2004 | B2 |
6712074 | Edwards et al. | Mar 2004 | B2 |
6712811 | Underwood et al. | Mar 2004 | B2 |
6712813 | Ellman et al. | Mar 2004 | B2 |
6712816 | Hung et al. | Mar 2004 | B2 |
6716211 | Mulier et al. | Apr 2004 | B2 |
6719754 | Underwood et al. | Apr 2004 | B2 |
6723094 | Desinger | Apr 2004 | B1 |
6726683 | Shaw | Apr 2004 | B1 |
6726684 | Woloszko et al. | Apr 2004 | B1 |
6726686 | Buysse et al. | Apr 2004 | B2 |
6730081 | Desai | May 2004 | B1 |
6733496 | Sharkey et al. | May 2004 | B2 |
6733498 | Paton et al. | May 2004 | B2 |
6733501 | Levine | May 2004 | B2 |
6736810 | Hoey et al. | May 2004 | B2 |
6740058 | Lal et al. | May 2004 | B2 |
6740079 | Eggers et al. | May 2004 | B1 |
6740082 | Shadduck | May 2004 | B2 |
6740084 | Ryan | May 2004 | B2 |
6740102 | Hess et al. | May 2004 | B2 |
6743197 | Edwards | Jun 2004 | B1 |
6743229 | Buysse et al. | Jun 2004 | B2 |
6743230 | Lutze et al. | Jun 2004 | B2 |
6746447 | Davison et al. | Jun 2004 | B2 |
6755825 | Shoenman et al. | Jun 2004 | B2 |
6755827 | Mulier et al. | Jun 2004 | B2 |
6757565 | Sharkey et al. | Jun 2004 | B2 |
6758846 | Goble et al. | Jul 2004 | B2 |
6761718 | Madsen | Jul 2004 | B2 |
6764487 | Mulier et al. | Jul 2004 | B2 |
6766202 | Underwood et al. | Jul 2004 | B2 |
6766817 | Da Silva | Jul 2004 | B2 |
6770070 | Balbierz | Aug 2004 | B1 |
6770071 | Woloszko et al. | Aug 2004 | B2 |
6770072 | Truckai et al. | Aug 2004 | B1 |
6772012 | Ricart et al. | Aug 2004 | B2 |
6772013 | Ingle et al. | Aug 2004 | B1 |
6775575 | Bommannan et al. | Aug 2004 | B2 |
6776780 | Mulier et al. | Aug 2004 | B2 |
6780177 | Shafirstein et al. | Aug 2004 | B2 |
6780180 | Goble et al. | Aug 2004 | B1 |
6786906 | Cobb | Sep 2004 | B1 |
6796981 | Wham et al. | Sep 2004 | B2 |
6800077 | Mucko et al. | Oct 2004 | B1 |
6802842 | Ellman et al. | Oct 2004 | B2 |
6802843 | Truckai et al. | Oct 2004 | B2 |
6808525 | Latterell et al. | Oct 2004 | B2 |
6813520 | Truckai et al. | Nov 2004 | B2 |
6814714 | Novak et al. | Nov 2004 | B1 |
6814731 | Swanson | Nov 2004 | B2 |
6821273 | Mollenauer | Nov 2004 | B2 |
6827713 | Bek et al. | Dec 2004 | B2 |
6827725 | Batchelor et al. | Dec 2004 | B2 |
6832996 | Woloszko | Dec 2004 | B2 |
6832997 | Uchida et al. | Dec 2004 | B2 |
6835195 | Schulze et al. | Dec 2004 | B2 |
6836688 | Ingle et al. | Dec 2004 | B2 |
6843789 | Goble | Jan 2005 | B2 |
6845264 | Skladnev et al. | Jan 2005 | B1 |
6849073 | Hoey et al. | Feb 2005 | B2 |
6855145 | Ciarrocca | Feb 2005 | B2 |
6858028 | Mulier et al. | Feb 2005 | B2 |
6860882 | Battles et al. | Mar 2005 | B2 |
6863669 | Spitzer | Mar 2005 | B2 |
6864686 | Novak et al. | Mar 2005 | B2 |
6881214 | Cosman et al. | Apr 2005 | B2 |
6882885 | Levy, Jr. et al. | Apr 2005 | B2 |
6887237 | McGaffigan | May 2005 | B2 |
6887240 | Lands et al. | May 2005 | B1 |
6893435 | Goble | May 2005 | B2 |
6893440 | Durgin et al. | May 2005 | B2 |
6896672 | Eggers et al. | May 2005 | B1 |
6896674 | Woloszko et al. | May 2005 | B1 |
6899712 | Moutafis et al. | May 2005 | B2 |
6905497 | Truckai et al. | Jun 2005 | B2 |
6905499 | Mucko et al. | Jun 2005 | B1 |
6911019 | Mulier et al. | Jun 2005 | B2 |
6915806 | Pacek et al. | Jul 2005 | B2 |
6918404 | Da Silva | Jul 2005 | B2 |
6921398 | Carmel et al. | Jul 2005 | B2 |
6921399 | Carmel et al. | Jul 2005 | B2 |
6923803 | Goble | Aug 2005 | B2 |
6923805 | LaFontaine et al. | Aug 2005 | B1 |
6926706 | Sealfon | Aug 2005 | B1 |
6926716 | Baker et al. | Aug 2005 | B2 |
6926717 | Garito et al. | Aug 2005 | B1 |
6929640 | Underwood et al. | Aug 2005 | B1 |
6929641 | Goble et al. | Aug 2005 | B2 |
6929642 | Xiao et al. | Aug 2005 | B2 |
6929644 | Truckai et al. | Aug 2005 | B2 |
6929645 | Battles et al. | Aug 2005 | B2 |
6932810 | Ryan | Aug 2005 | B2 |
6932815 | Sutter | Aug 2005 | B2 |
6942661 | Swanson | Sep 2005 | B2 |
6949096 | Davison et al. | Sep 2005 | B2 |
6949098 | Mulier et al. | Sep 2005 | B2 |
6951559 | Greep | Oct 2005 | B1 |
6953461 | McClurken et al. | Oct 2005 | B2 |
6960204 | Eggers et al. | Nov 2005 | B2 |
6960207 | Vanney et al. | Nov 2005 | B2 |
6960210 | Lands et al. | Nov 2005 | B2 |
6962589 | Mulier et al. | Nov 2005 | B2 |
6964274 | Ryan et al. | Nov 2005 | B1 |
6964661 | Rioux et al. | Nov 2005 | B2 |
6966907 | Goble | Nov 2005 | B2 |
6966909 | Marshall et al. | Nov 2005 | B2 |
6971394 | Sliwa, Jr. et al. | Dec 2005 | B2 |
6974452 | Gille et al. | Dec 2005 | B1 |
6974453 | Woloszko et al. | Dec 2005 | B2 |
6979332 | Adams | Dec 2005 | B2 |
6984231 | Goble et al. | Jan 2006 | B2 |
6986769 | Nelson et al. | Jan 2006 | B2 |
6991631 | Woloszko et al. | Jan 2006 | B2 |
7001380 | Goble | Feb 2006 | B2 |
7001382 | Gallo, Sr. | Feb 2006 | B2 |
7004941 | Tvinnereim et al. | Feb 2006 | B2 |
7004942 | Laird et al. | Feb 2006 | B2 |
7008419 | Shadduck | Mar 2006 | B2 |
7008421 | Daniel et al. | Mar 2006 | B2 |
7033348 | Alfano et al. | Apr 2006 | B2 |
7033356 | Latterell et al. | Apr 2006 | B2 |
7041096 | Malis et al. | May 2006 | B2 |
7041101 | Eggers | May 2006 | B2 |
7041102 | Truckai et al. | May 2006 | B2 |
7052494 | Goble et al. | May 2006 | B2 |
7060064 | Allen et al. | Jun 2006 | B2 |
7063670 | Sampson et al. | Jun 2006 | B2 |
7066586 | Da Silva | Jun 2006 | B2 |
7066932 | Morgan et al. | Jun 2006 | B1 |
7066936 | Ryan | Jun 2006 | B2 |
7070596 | Woloszko et al. | Jul 2006 | B1 |
7070604 | Garito et al. | Jul 2006 | B1 |
7074217 | Strul et al. | Jul 2006 | B2 |
7074219 | Levine et al. | Jul 2006 | B2 |
7083601 | Cosmescu | Aug 2006 | B1 |
7087051 | Bourne et al. | Aug 2006 | B2 |
7087053 | Vanney | Aug 2006 | B2 |
7094215 | Davison et al. | Aug 2006 | B2 |
7101387 | Garabedian et al. | Sep 2006 | B2 |
7104986 | Hovda et al. | Sep 2006 | B2 |
7112199 | Cosmescu | Sep 2006 | B2 |
7115139 | McClurken et al. | Oct 2006 | B2 |
7125406 | Given | Oct 2006 | B2 |
7147634 | Nesbitt | Dec 2006 | B2 |
7147635 | Ciarrocca | Dec 2006 | B2 |
7147637 | Goble | Dec 2006 | B2 |
7147638 | Chapman et al. | Dec 2006 | B2 |
7150746 | DeCesare et al. | Dec 2006 | B2 |
7150747 | McDonald et al. | Dec 2006 | B1 |
7150748 | Ebbutt et al. | Dec 2006 | B2 |
7153300 | Goble | Dec 2006 | B2 |
7156845 | Mulier et al. | Jan 2007 | B2 |
7166105 | Mulier et al. | Jan 2007 | B2 |
7166106 | Bartel et al. | Jan 2007 | B2 |
7169143 | Eggers et al. | Jan 2007 | B2 |
7169144 | Hoey et al. | Jan 2007 | B2 |
7207471 | Heinrich et al. | Apr 2007 | B2 |
7232440 | Dumbauld et al. | Jun 2007 | B2 |
7247155 | Hoey et al. | Jul 2007 | B2 |
7261711 | Mulier et al. | Aug 2007 | B2 |
7309325 | Mulier et al. | Dec 2007 | B2 |
7311708 | McClurken | Dec 2007 | B2 |
7322974 | Swoyer et al. | Jan 2008 | B2 |
7361175 | Suslov | Apr 2008 | B2 |
7364579 | Mulier et al. | Apr 2008 | B2 |
20010014819 | Ingle et al. | Aug 2001 | A1 |
20010020167 | Woloszko et al. | Sep 2001 | A1 |
20010023365 | Medhkour et al. | Sep 2001 | A1 |
20010025178 | Mulier et al. | Sep 2001 | A1 |
20010032002 | McClurken et al. | Oct 2001 | A1 |
20010039419 | Francischelli et al. | Nov 2001 | A1 |
20010041921 | Mulier et al. | Nov 2001 | A1 |
20010051802 | Woloszko et al. | Dec 2001 | A1 |
20010051804 | Mulier et al. | Dec 2001 | A1 |
20020002393 | Mitchell | Jan 2002 | A1 |
20020010463 | Mulier et al. | Jan 2002 | A1 |
20020013582 | Mulier et al. | Jan 2002 | A1 |
20020016589 | Swartz et al. | Feb 2002 | A1 |
20020019628 | Comben | Feb 2002 | A1 |
20020022870 | Truckai et al. | Feb 2002 | A1 |
20020026186 | Woloszko et al. | Feb 2002 | A1 |
20020026187 | Swanson | Feb 2002 | A1 |
20020029036 | Goble et al. | Mar 2002 | A1 |
20020035361 | Houser et al. | Mar 2002 | A1 |
20020035387 | Mulier et al. | Mar 2002 | A1 |
20020049438 | Sharkey et al. | Apr 2002 | A1 |
20020049439 | Mulier et al. | Apr 2002 | A1 |
20020049483 | Knowlton | Apr 2002 | A1 |
20020058933 | Christopherson et al. | May 2002 | A1 |
20020058935 | Hoey et al. | May 2002 | A1 |
20020062123 | McClurken et al. | May 2002 | A1 |
20020095150 | Goble | Jul 2002 | A1 |
20020095151 | Dahla et al. | Jul 2002 | A1 |
20020095152 | Ciarrocca et al. | Jul 2002 | A1 |
20020099366 | Dahla et al. | Jul 2002 | A1 |
20020115991 | Edwards | Aug 2002 | A1 |
20020115992 | Utley et al. | Aug 2002 | A1 |
20020120259 | Lettice et al. | Aug 2002 | A1 |
20020120260 | Morris et al. | Aug 2002 | A1 |
20020120261 | Morris et al. | Aug 2002 | A1 |
20020128650 | McClurken | Sep 2002 | A1 |
20020133148 | Daniel et al. | Sep 2002 | A1 |
20020151884 | Hoey et al. | Oct 2002 | A1 |
20020156511 | Habib | Oct 2002 | A1 |
20020161364 | Mulier et al. | Oct 2002 | A1 |
20020169446 | Mulier et al. | Nov 2002 | A1 |
20020177846 | Mulier et al. | Nov 2002 | A1 |
20020183733 | Mulier et al. | Dec 2002 | A1 |
20020188284 | To et al. | Dec 2002 | A1 |
20020193851 | Silverman et al. | Dec 2002 | A1 |
20020198524 | Mulier et al. | Dec 2002 | A1 |
20030014050 | Sharkey et al. | Jan 2003 | A1 |
20030032954 | Carranza et al. | Feb 2003 | A1 |
20030032955 | Mulier et al. | Feb 2003 | A1 |
20030073989 | Hoey et al. | Apr 2003 | A1 |
20030073993 | Ciarrocca | Apr 2003 | A1 |
20030114850 | McClurken et al. | Jun 2003 | A1 |
20030181902 | Mulier et al. | Sep 2003 | A1 |
20030204185 | Sherman et al. | Oct 2003 | A1 |
20030216733 | McClurken et al. | Nov 2003 | A1 |
20040015162 | McGaffigan | Jan 2004 | A1 |
20040015163 | Buysse et al. | Jan 2004 | A1 |
20040015215 | Fredricks et al. | Jan 2004 | A1 |
20040015216 | DeSisto | Jan 2004 | A1 |
20040015218 | Finch et al. | Jan 2004 | A1 |
20040019350 | O'Brien et al. | Jan 2004 | A1 |
20040024395 | Ellman et al. | Feb 2004 | A1 |
20040024396 | Eggers | Feb 2004 | A1 |
20040024398 | Hovda et al. | Feb 2004 | A1 |
20040024399 | Sharps et al. | Feb 2004 | A1 |
20040030327 | Golan | Feb 2004 | A1 |
20040030328 | Eggers et al. | Feb 2004 | A1 |
20040030330 | Brassell et al. | Feb 2004 | A1 |
20040030332 | Knowlton et al. | Feb 2004 | A1 |
20040030333 | Goble | Feb 2004 | A1 |
20040034340 | Biscup | Feb 2004 | A1 |
20040034346 | Stern et al. | Feb 2004 | A1 |
20040034349 | Kirwan, Jr. et al. | Feb 2004 | A1 |
20040034400 | Ingle et al. | Feb 2004 | A1 |
20040039429 | Daniel et al. | Feb 2004 | A1 |
20040044341 | Truckai et al. | Mar 2004 | A1 |
20040054363 | Vaska et al. | Mar 2004 | A1 |
20040054365 | Goble | Mar 2004 | A1 |
20040054366 | Davison et al. | Mar 2004 | A1 |
20040054369 | Nelson et al. | Mar 2004 | A1 |
20040054370 | Given | Mar 2004 | A1 |
20040059328 | Daniel et al. | Mar 2004 | A1 |
20040059363 | Alvarez et al. | Mar 2004 | A1 |
20040064023 | Ryan et al. | Apr 2004 | A1 |
20040064137 | Pellegrino et al. | Apr 2004 | A1 |
20040068306 | Shadduck | Apr 2004 | A1 |
20040068307 | Goble | Apr 2004 | A1 |
20040073205 | Treat et al. | Apr 2004 | A1 |
20040073208 | Sutter | Apr 2004 | A1 |
20040078034 | Acker et al. | Apr 2004 | A1 |
20040078037 | Batchelor et al. | Apr 2004 | A1 |
20040078038 | Desinger et al. | Apr 2004 | A1 |
20040082946 | Malis et al. | Apr 2004 | A1 |
20040082952 | Dycus et al. | Apr 2004 | A1 |
20040087937 | Eggers et al. | May 2004 | A1 |
20040087939 | Eggers et al. | May 2004 | A1 |
20040087940 | Jahns et al. | May 2004 | A1 |
20040087943 | Dycus et al. | May 2004 | A1 |
20040088029 | Yamamoto | May 2004 | A1 |
20040092925 | Rizoiu et al. | May 2004 | A1 |
20040092926 | Hoey et al. | May 2004 | A1 |
20040097919 | Wellman et al. | May 2004 | A1 |
20040102770 | Goble | May 2004 | A1 |
20040102824 | Sharkey et al. | May 2004 | A1 |
20040111136 | Sharkey et al. | Jun 2004 | A1 |
20040111137 | Sharkey et al. | Jun 2004 | A1 |
20040116923 | Desinger | Jun 2004 | A1 |
20040122420 | Amoah | Jun 2004 | A1 |
20040122423 | Dycus et al. | Jun 2004 | A1 |
20040122494 | Eggers et al. | Jun 2004 | A1 |
20040138654 | Goble | Jul 2004 | A1 |
20040138655 | McClurken et al. | Jul 2004 | A1 |
20040138657 | Bourne et al. | Jul 2004 | A1 |
20040143257 | Fuimaono | Jul 2004 | A1 |
20040143258 | Fuimaono | Jul 2004 | A1 |
20040143259 | Mulier et al. | Jul 2004 | A1 |
20040143263 | Schechter et al. | Jul 2004 | A1 |
20040147902 | McGuckin, Jr. et al. | Jul 2004 | A1 |
20040147916 | Baker | Jul 2004 | A1 |
20040147922 | Keppel | Jul 2004 | A1 |
20040147925 | Buysse et al. | Jul 2004 | A1 |
20040162552 | McClurken | Aug 2004 | A1 |
20040162554 | Lee et al. | Aug 2004 | A1 |
20040162557 | Tetzlaff et al. | Aug 2004 | A1 |
20040162572 | Sauer | Aug 2004 | A1 |
20040167508 | Wham et al. | Aug 2004 | A1 |
20040172111 | Hijii et al. | Sep 2004 | A1 |
20040176760 | Qiu | Sep 2004 | A1 |
20040176761 | Desinger | Sep 2004 | A1 |
20040176762 | Lawes et al. | Sep 2004 | A1 |
20040181219 | Goble et al. | Sep 2004 | A1 |
20040181250 | Adams et al. | Sep 2004 | A1 |
20040186469 | Woloszko et al. | Sep 2004 | A1 |
20040186470 | Goble et al. | Sep 2004 | A1 |
20040186535 | Knowlton | Sep 2004 | A1 |
20040193148 | Wham et al. | Sep 2004 | A1 |
20040193150 | Sharkey et al. | Sep 2004 | A1 |
20040193152 | Sutton et al. | Sep 2004 | A1 |
20040193211 | Voegele et al. | Sep 2004 | A1 |
20040199156 | Rioux et al. | Oct 2004 | A1 |
20040199160 | Slater | Oct 2004 | A1 |
20040206365 | Knowlton | Oct 2004 | A1 |
20040210213 | Fuimaono et al. | Oct 2004 | A1 |
20040210214 | Knowlton | Oct 2004 | A1 |
20040215181 | Christopherson et al. | Oct 2004 | A1 |
20040215182 | Lee | Oct 2004 | A1 |
20040215183 | Hoey et al. | Oct 2004 | A1 |
20040215184 | Eggers et al. | Oct 2004 | A1 |
20040215185 | Truckai et al. | Oct 2004 | A1 |
20040215188 | Mulier et al. | Oct 2004 | A1 |
20040215235 | Jackson et al. | Oct 2004 | A1 |
20040215296 | Ganz et al. | Oct 2004 | A1 |
20040220561 | Kirwan, Jr. et al. | Nov 2004 | A1 |
20040220562 | Garabedian et al. | Nov 2004 | A1 |
20040225288 | Buysse et al. | Nov 2004 | A1 |
20040230190 | Dahla et al. | Nov 2004 | A1 |
20040236322 | Mulier et al. | Nov 2004 | A1 |
20040236324 | Muller et al. | Nov 2004 | A1 |
20040243125 | Dycus et al. | Dec 2004 | A1 |
20040243163 | Casiano et al. | Dec 2004 | A1 |
20040249371 | Dycus et al. | Dec 2004 | A1 |
20040249374 | Tetzlaff et al. | Dec 2004 | A1 |
20040249425 | Roy et al. | Dec 2004 | A1 |
20040260279 | Goble et al. | Dec 2004 | A1 |
20040260280 | Sartor | Dec 2004 | A1 |
20040260368 | Ingle et al. | Dec 2004 | A1 |
20050010205 | Hovda et al. | Jan 2005 | A1 |
20050010212 | McClurken et al. | Jan 2005 | A1 |
20050015085 | McClurken et al. | Jan 2005 | A1 |
20050015086 | Platt | Jan 2005 | A1 |
20050015130 | Gill | Jan 2005 | A1 |
20050021025 | Buysse et al. | Jan 2005 | A1 |
20050021026 | Baily | Jan 2005 | A1 |
20050021027 | Shields et al. | Jan 2005 | A1 |
20050033278 | McClurken et al. | Feb 2005 | A1 |
20050033292 | Teitelbaum et al. | Feb 2005 | A1 |
20050038471 | Chan et al. | Feb 2005 | A1 |
20050043728 | Ciarrocca | Feb 2005 | A1 |
20050049583 | Swanson | Mar 2005 | A1 |
20050049586 | Daniel et al. | Mar 2005 | A1 |
20050055019 | Skarda | Mar 2005 | A1 |
20050055020 | Skarda | Mar 2005 | A1 |
20050059966 | McClurken et al. | Mar 2005 | A1 |
20050070888 | Dimatteo et al. | Mar 2005 | A1 |
20050070891 | DeSisto | Mar 2005 | A1 |
20050070894 | McClurken | Mar 2005 | A1 |
20050070896 | Daniel et al. | Mar 2005 | A1 |
20050080410 | Rioux et al. | Apr 2005 | A1 |
20050080413 | Canady | Apr 2005 | A1 |
20050085804 | McGaffigan | Apr 2005 | A1 |
20050085809 | Mucko et al. | Apr 2005 | A1 |
20050085880 | Truckai et al. | Apr 2005 | A1 |
20050090816 | McClurken et al. | Apr 2005 | A1 |
20050090819 | Goble | Apr 2005 | A1 |
20050096649 | Adams | May 2005 | A1 |
20050096651 | Truckai et al. | May 2005 | A1 |
20050101951 | Wham et al. | May 2005 | A1 |
20050101952 | Lands et al. | May 2005 | A1 |
20050101965 | Ryan | May 2005 | A1 |
20050107778 | Rioux et al. | May 2005 | A1 |
20050107779 | Ellman et al. | May 2005 | A1 |
20050107784 | Moses et al. | May 2005 | A1 |
20050107786 | Canady | May 2005 | A1 |
20050113820 | Goble et al. | May 2005 | A1 |
20050113825 | Cosmescu | May 2005 | A1 |
20050124987 | Goble | Jun 2005 | A1 |
20050130929 | Boyd | Jun 2005 | A1 |
20050131402 | Ciarrocca et al. | Jun 2005 | A1 |
20050137590 | Lawes et al. | Jun 2005 | A1 |
20050137662 | Morris et al. | Jun 2005 | A1 |
20050143729 | Francischelli et al. | Jun 2005 | A1 |
20050154385 | Heim et al. | Jul 2005 | A1 |
20050154433 | Levy, Jr. et al. | Jul 2005 | A1 |
20050159739 | Paul et al. | Jul 2005 | A1 |
20050159740 | Paul et al. | Jul 2005 | A1 |
20050159778 | Heinrich et al. | Jul 2005 | A1 |
20050159797 | Chandran et al. | Jul 2005 | A1 |
20050165444 | Hart et al. | Jul 2005 | A1 |
20050171524 | Stern et al. | Aug 2005 | A1 |
20050171526 | Rioux et al. | Aug 2005 | A1 |
20050171532 | Ciarrocca | Aug 2005 | A1 |
20050171533 | Latterell et al. | Aug 2005 | A1 |
20050171534 | Habib | Aug 2005 | A1 |
20050171583 | Mosher et al. | Aug 2005 | A1 |
20050177150 | Amoah et al. | Aug 2005 | A1 |
20050177209 | Leung et al. | Aug 2005 | A1 |
20050187543 | Underwood et al. | Aug 2005 | A1 |
20050187599 | Sharkey et al. | Aug 2005 | A1 |
20050203503 | Edwards et al. | Sep 2005 | A1 |
20050203504 | Wham et al. | Sep 2005 | A1 |
20050209591 | Sutter | Sep 2005 | A1 |
20050209621 | Gordon et al. | Sep 2005 | A1 |
20050222602 | Sutter et al. | Oct 2005 | A1 |
20050222611 | WeitKamp | Oct 2005 | A1 |
20050228372 | Truckai et al. | Oct 2005 | A1 |
20050245918 | Sliwa, Jr. et al. | Nov 2005 | A1 |
20050245921 | Strul et al. | Nov 2005 | A1 |
20050245922 | Goble | Nov 2005 | A1 |
20050245923 | Christopherson et al. | Nov 2005 | A1 |
20050250477 | Eastwood et al. | Nov 2005 | A1 |
20050251128 | Amoah | Nov 2005 | A1 |
20050251134 | Woloszko et al. | Nov 2005 | A1 |
20050256519 | Goble et al. | Nov 2005 | A1 |
20050261676 | Hall et al. | Nov 2005 | A1 |
20050261677 | Hall et al. | Nov 2005 | A1 |
20050267465 | Hillier et al. | Dec 2005 | A1 |
20050267467 | Paul et al. | Dec 2005 | A1 |
20050267468 | Truckai et al. | Dec 2005 | A1 |
20050267469 | Blocher | Dec 2005 | A1 |
20050273092 | G. et al. | Dec 2005 | A1 |
20050273097 | Ryan | Dec 2005 | A1 |
20050277915 | DeCesare et al. | Dec 2005 | A1 |
20050277916 | DeCesare et al. | Dec 2005 | A1 |
20050277917 | Garito et al. | Dec 2005 | A1 |
20050283147 | Yachi | Dec 2005 | A1 |
20050283148 | Janssen et al. | Dec 2005 | A1 |
20050283149 | Thorne et al. | Dec 2005 | A1 |
20050283150 | Moutafis et al. | Dec 2005 | A1 |
20050283151 | Ebbutt et al. | Dec 2005 | A1 |
20050288661 | Sauvageau et al. | Dec 2005 | A1 |
20050288665 | Woloszko | Dec 2005 | A1 |
20060004356 | Bilski et al. | Jan 2006 | A1 |
20060009760 | Mulier et al. | Jan 2006 | A1 |
20060009762 | Whayne | Jan 2006 | A1 |
20060015097 | Mulier et al. | Jan 2006 | A1 |
20060020265 | Ryan | Jan 2006 | A1 |
20060025765 | Landman et al. | Feb 2006 | A1 |
20060025766 | Heinrich et al. | Feb 2006 | A1 |
20060030912 | Eggers et al. | Feb 2006 | A1 |
20060036235 | Swoyer et al. | Feb 2006 | A1 |
20060036237 | Davison et al. | Feb 2006 | A1 |
20060036239 | Canady | Feb 2006 | A1 |
20060041254 | Francischelli et al. | Feb 2006 | A1 |
20060041255 | Eggers et al. | Feb 2006 | A1 |
20060047275 | Goble | Mar 2006 | A1 |
20060047280 | Goble et al. | Mar 2006 | A1 |
20060047331 | Lax et al. | Mar 2006 | A1 |
20060052770 | Mulier et al. | Mar 2006 | A1 |
20060064085 | Schechter et al. | Mar 2006 | A1 |
20060064101 | Arramon | Mar 2006 | A1 |
20060074411 | Carmel et al. | Apr 2006 | A1 |
20060074414 | Mulier et al. | Apr 2006 | A1 |
20060079872 | Eggleston | Apr 2006 | A1 |
20060079888 | Mulier et al. | Apr 2006 | A1 |
20060084968 | Truckai et al. | Apr 2006 | A1 |
20060095026 | Ricart et al. | May 2006 | A1 |
20060095031 | Ormsby | May 2006 | A1 |
20060095034 | Garito et al. | May 2006 | A1 |
20060095075 | Burkinshaw et al. | May 2006 | A1 |
20060095103 | Eggers et al. | May 2006 | A1 |
20060100619 | McClurken et al. | May 2006 | A1 |
20060106376 | Godara et al. | May 2006 | A1 |
20060106379 | O'Brien et al. | May 2006 | A1 |
20060111705 | Janzen et al. | May 2006 | A1 |
20060111709 | Goble et al. | May 2006 | A1 |
20060111710 | Goble et al. | May 2006 | A1 |
20060111711 | Goble | May 2006 | A1 |
20060111741 | Nardella | May 2006 | A1 |
20060116675 | McClurken et al. | Jun 2006 | A1 |
20060122593 | Jun et al. | Jun 2006 | A1 |
20060129145 | Woloszko et al. | Jun 2006 | A1 |
20060129185 | Paternuosto | Jun 2006 | A1 |
20060142757 | Daniel et al. | Jun 2006 | A1 |
20060149225 | McClurken | Jul 2006 | A1 |
20060167446 | Pozzato | Jul 2006 | A1 |
20060167449 | Mulier et al. | Jul 2006 | A1 |
20060167451 | Cropper | Jul 2006 | A1 |
20060178667 | Sartor et al. | Aug 2006 | A1 |
20060178668 | Albritton, IV | Aug 2006 | A1 |
20060178670 | Woloszko et al. | Aug 2006 | A1 |
20060178699 | Surti | Aug 2006 | A1 |
20060184164 | Malis et al. | Aug 2006 | A1 |
20060184167 | Vaska et al. | Aug 2006 | A1 |
20060189977 | Allen et al. | Aug 2006 | A1 |
20060189979 | Esch et al. | Aug 2006 | A1 |
20060195079 | Eberl | Aug 2006 | A1 |
20060200123 | Ryan | Sep 2006 | A1 |
20060217700 | Garito et al. | Sep 2006 | A1 |
20060217701 | Young et al. | Sep 2006 | A1 |
20060217707 | Daniel et al. | Sep 2006 | A1 |
20060224154 | Shadduck et al. | Oct 2006 | A1 |
20060235286 | Stone et al. | Oct 2006 | A1 |
20060235377 | Earley et al. | Oct 2006 | A1 |
20060235379 | McClurken et al. | Oct 2006 | A1 |
20060241577 | Balbierz et al. | Oct 2006 | A1 |
20060241587 | Heim et al. | Oct 2006 | A1 |
20060241588 | Heim et al. | Oct 2006 | A1 |
20060241589 | Heim et al. | Oct 2006 | A1 |
20060247614 | Sampson et al. | Nov 2006 | A1 |
20060259025 | Dahla | Nov 2006 | A1 |
20060259031 | Carmel et al. | Nov 2006 | A1 |
20060259070 | Livneh | Nov 2006 | A1 |
20060264927 | Ryan | Nov 2006 | A1 |
20060264929 | Goble et al. | Nov 2006 | A1 |
20060264931 | Chapman et al. | Nov 2006 | A1 |
20060271033 | Ein-Gal | Nov 2006 | A1 |
20060271036 | Garabedian et al. | Nov 2006 | A1 |
20060271042 | Latterell et al. | Nov 2006 | A1 |
20060276783 | Cosmescu | Dec 2006 | A1 |
20060276785 | Asahara et al. | Dec 2006 | A1 |
20070000501 | Wert et al. | Jan 2007 | A1 |
20070010812 | Mittelstein et al. | Jan 2007 | A1 |
20070016182 | Lipson et al. | Jan 2007 | A1 |
20070049920 | McClurken et al. | Mar 2007 | A1 |
20070093808 | Mulier et al. | Apr 2007 | A1 |
20070118114 | Miller et al. | May 2007 | A1 |
20070208332 | Mulier et al. | Sep 2007 | A1 |
20080015563 | Hoey et al. | Jan 2008 | A1 |
20080071270 | Baker et al. | Mar 2008 | A1 |
Number | Date | Country |
---|---|---|
1 007 960 | May 1957 | DE |
0 175 595 | Mar 1986 | EP |
0 895 756 | Feb 1999 | EP |
1 095 627 | May 2001 | EP |
1 157 666 | Nov 2001 | EP |
2 235 669 | Jan 1975 | FR |
57-117843 | Jul 1982 | JP |
5-092009 | Apr 1993 | JP |
7-124245 | May 1995 | JP |
WO 9003152 | Apr 1990 | WO |
WO 9402077 | Feb 1994 | WO |
WO 9426228 | Nov 1994 | WO |
WO 9505781 | Mar 1995 | WO |
WO 9509570 | Apr 1995 | WO |
WO 9517222 | Jun 1995 | WO |
WO 9634571 | Nov 1996 | WO |
WO 9705829 | Feb 1997 | WO |
WO 9705829 | Feb 1997 | WO |
WO 9716127 | May 1997 | WO |
WO 9814131 | Apr 1998 | WO |
WO 9838932 | Sep 1998 | WO |
WO 9903414 | Jan 1999 | WO |
WO 9920213 | Apr 1999 | WO |
WO 9958070 | Nov 1999 | WO |
WO 9966850 | Dec 1999 | WO |
WO 0078240 | Dec 2000 | WO |
WO 0126570 | Apr 2001 | WO |
WO 0128444 | Apr 2001 | WO |
WO 0135845 | May 2001 | WO |
WO 0160273 | Aug 2001 | WO |
WO 0166026 | Sep 2001 | WO |
WO 0180757 | Nov 2001 | WO |
WO 2005122938 | Dec 2005 | WO |
WO 2006062916 | Jun 2006 | WO |
WO 2006062939 | Jun 2006 | WO |
Number | Date | Country | |
---|---|---|---|
20040138655 A1 | Jul 2004 | US |
Number | Date | Country | |
---|---|---|---|
60187114 | Mar 2000 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09797049 | Mar 2001 | US |
Child | 10746222 | US |